Use of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia (CML)
Chronic Myeloid Leukemia is a hematological cancer that comes from translocation between chromosomes 9:22 t(9:22) (q34; 11), from which originates the BCR-ABL hybrid gene that is responsible for the alteration of protein kinase in leukemic cells. This atypical chromosome is called the Philadelphia c...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidade Federal de Rondonópolis
2016-11-01
|
| Series: | Scientific Electronic Archives |
| Subjects: | |
| Online Access: | https://sea.ufr.edu.br/index.php?journal=SEA&page=article&op=view&path=310 |